Application

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 12/31/2008)

---

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 12/31/2008)

Trademark/Service Mark Application, Principal Register

Serial Number: 77673768

Filing Date: 02/19/2009

To the Commissioner for Trademarks:

MARK: OXFORD BIOMEDICA (Standard Characters, see mark)
The literal element of the mark consists of OXFORD BIOMEDICA.
The mark consists of standard characters, without claim to any particular font, style, size, or color.

The applicant, Oxford BioMedica plc, a company organized under the laws of United Kingdom, having an address of
      The Oxford Science Park,
      Medawar Centre, Robert Robinson Avenue
      Oxford OX44GA
      United Kingdom
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended.

       International Class 001:  Chemical products for use in industry and science; enzymes; chemical products for in-vitro use in laboratories and for analysis; micro-organisms, viruses, cell cultures, plasmids and cultures of micro-organisms, nucleic acid sequences, cloning vehicles, chemical products for use in biotechnology, research and development and recombinant nucleic acid variations thereof, all for in-vivo use
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).

Priority based on foreign filing: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services and asserts a claim of priority based on European Community application number 8110744, filed 02/18/2009. 15 U.S.C. Section 1126(d), as amended.


       International Class 005:  Therapeutic and prophylactic products; gene therapy products; pharmaceutical substances and preparations; small molecules, vaccines, biologics, enzymes and enzyme preparations, pharmaceuticals for the delivery of genes to cells, all for medical purposes; viral, retroviral and non-viral vectors; viral, retroviral and non-viral vector manufacturing preparations; biochemical and chemical products for use in medical science; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).

Priority based on foreign filing: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services and asserts a claim of priority based on European Community application number 8110744, filed 02/18/2009. 15 U.S.C. Section 1126(d), as amended.


       International Class 010:  Instruments and apparatus for the administration of pharmaceutical, gene therapy and/or vaccine preparations and substances, pre-filled vials; syringes and injectors for medical purposes
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).

Priority based on foreign filing: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services and asserts a claim of priority based on European Community application number 8110744, filed 02/18/2009. 15 U.S.C. Section 1126(d), as amended.


       International Class 042:  Scientific, pharmaceutical and medical research and development; genetic engineering services, biotechnology services, advisory services relating to gene therapy products and clinical trials, conducting clinical trials
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).

Priority based on foreign filing: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services and asserts a claim of priority based on European Community application number 8110744, filed 02/18/2009. 15 U.S.C. Section 1126(d), as amended.


       International Class 044:  Medical services; advisory services relating to vaccination regimes; advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases, reproductive system disorders, and pharmaceutical and biochemical preparations for contraceptive purposes, in humans and animals
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).

Priority based on foreign filing: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services and asserts a claim of priority based on European Community application number 8110744, filed 02/18/2009. 15 U.S.C. Section 1126(d), as amended.



The applicant hereby appoints Howard N. Aronson and Nancy Dwyer Chapman, Renee L. Duff, Cathy E. Shore-Sirotin of Lackenbach Siegel LLP
      Lackenbach Siegel Building
      One Chase Road
      Scarsdale, New York 10583
      United States
to submit this application on behalf of the applicant. The attorney docket/reference number is 14058.

The applicant hereby appoints Howard N. Aronson of Lackenbach Siegel LLP
      Lackenbach Siegel Building
      One Chase Road
      Scarsdale New York 10583
      United States
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

Correspondence Information:	Howard N. Aronson
	Lackenbach Siegel Building
	One Chase Road
	Scarsdale, New York 10583
	914-723-4300(phone)
	914-723-4301(fax)
	TMEFS@LSLLP.COM (authorized)

A fee payment in the amount of $1625 has been submitted with the application, representing payment for 5 class(es).

Declaration

The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.


Signature: /Nancy Dwyer Chapman/   Date Signed: 02/19/2009
Signatory's Name: Nancy Dwyer Chapman
Signatory's Position: Attorney of Record, New York State Bar Member



RAM Sale Number: 10836
RAM Accounting Date: 02/19/2009

Serial Number: 77673768
Internet Transmission Date: Thu Feb 19 14:16:53 EST 2009
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2009021914165334
1548-77673768-4409888d67c7e628aa91bedbff
f8eb29da7-DA-10836-20090219140247431970